Northwestern Mutual Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Buy |
7,380
+507
| +7% | +$24.7K | ﹤0.01% | 1517 |
|
|
2025
Q1 | $234K | Buy |
6,873
+2,949
| +75% | +$100K | ﹤0.01% | 1602 |
|
|
2024
Q4 | $154K | Sell |
3,924
-746
| -16% | -$29.4K | ﹤0.01% | 1758 |
|
|
2024
Q3 | $219K | Buy |
4,670
+64
| +1% | +$3.01K | ﹤0.01% | 1596 |
|
|
2024
Q2 | $249K | Buy |
4,606
+211
| +5% | +$11.4K | ﹤0.01% | 1495 |
|
|
2024
Q1 | $300K | Buy |
4,395
+2,002
| +84% | +$136K | ﹤0.01% | 1410 |
|
|
2023
Q4 | $150K | Buy |
2,393
+101
| +4% | +$6.32K | ﹤0.01% | 1614 |
|
|
2023
Q3 | $104K | Buy |
2,292
+62
| +3% | +$2.81K | ﹤0.01% | 1699 |
|
|
2023
Q2 | $125K | Buy |
2,230
+363
| +19% | +$20.4K | ﹤0.01% | 1629 |
|
|
2023
Q1 | $84.4K | Buy |
1,867
+503
| +37% | +$22.8K | ﹤0.01% | 1748 |
|
|
2022
Q4 | $55.4K | Sell |
1,364
-873
| -39% | -$35.5K | ﹤0.01% | 1879 |
|
|
2022
Q3 | $146K | Buy |
2,237
+1,316
| +143% | +$85.9K | ﹤0.01% | 1497 |
|
|
2022
Q2 | $56K | Buy |
921
+428
| +87% | +$26K | ﹤0.01% | 1874 |
|
|
2022
Q1 | $31K | Sell |
493
-285
| -37% | -$17.9K | ﹤0.01% | 2132 |
|
|
2021
Q4 | $59K | Hold |
778
| – | – | ﹤0.01% | 1920 |
|
|
2021
Q3 | $87K | Sell |
778
-78
| -9% | -$8.72K | ﹤0.01% | 1690 |
|
|
2021
Q2 | $139K | Buy |
856
+531
| +163% | +$86.2K | ﹤0.01% | 1465 |
|
|
2021
Q1 | $40K | Buy |
325
+275
| +550% | +$33.8K | ﹤0.01% | 1817 |
|
|
2020
Q4 | $8K | Sell |
50
-8
| -14% | -$1.28K | ﹤0.01% | 2254 |
|
|
2020
Q3 | $5K | Buy |
+58
| New | +$5K | ﹤0.01% | 2165 |
|